V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160011962 | 160016702 | 1.81 | 52.8 | Neo-adjuvant (N) | 2018-06-29 | 2018-07-11 | CISPLATIN + ETOPOSIDE | 02 | null | NB HRNBL-1 BUMEL MAT | 100667890 |
| 160012068 | 160016703 | 0 | 28.4 | Palliative (P) | 2019-10-22 | 2019-11-05 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | null | IRINOTECAN + VINCRISTINE | 101598329 |
| 160012150 | 160016704 | 0 | 64.4 | null | 2019-01-03 | 2019-01-09 | Vincristine (weekly) | 02 | null | CONFIRM TRIAL | 100388806 |
| 160012281 | 160016705 | 1.45 | 15.8 | Palliative (P) | 2018-09-11 | 2019-01-02 | STS Rhabdomyosarcoma RMS 2005 IVA | null | N | EURO-EWING | 101765114 |
| 160012366 | 160016706 | 0 | 74.7 | null | 2017-12-07 | 2017-12-07 | STS Rhabdomyosarcoma RMS 2005 IVA | 01 | null | CYCLOPHOSPHAMIDE + TOPOTECAN | 100358644 |
| 160012455 | 160016707 | null | 53.4 | null | 2012-11-14 | 2018-02-28 | IVADo | 01 | null | DACARBAZINE | 100067373 |
| 160012721 | 160016709 | 0 | 58.6 | null | 2014-12-02 | 2014-12-04 | NB HRNBL-1 BUMEL MAT | 02 | null | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101777446 |
| 160012860 | 160016710 | 1.6 | 94 | Curative (C) | 2019-09-14 | 2019-09-14 | Trial Unspecified | 02 | null | CARBOPLATIN + VINORELBINE | 100453526 |
| 160013122 | 160016711 | 1.84 | 55.3 | Palliative (P) | 2020-01-10 | 2020-01-18 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | ETOPOSIDE | 100659814 |
| 160013237 | 160016712 | 1.72 | 74 | null | 2018-03-04 | 2018-03-05 | Olaratumab | 01 | null | DOXORUBICIN + IFOSFAMIDE | 100446913 |
| 160013416 | 160016714 | 1.62 | 58.2 | null | 2018-06-29 | 2018-07-06 | Capecitabine + Oxaliplatin 21day | 02 | null | IFOSFAMIDE | 101195834 |
| 160013461 | 160016715 | 0 | 72.6 | Not known (9) | 2019-10-26 | 2019-10-28 | PEMBROLIZUMAB | 02 | N | CYCLOPHOSPHAMIDE + VINCRISTINE | 101452805 |
| 160013479 | 160016716 | 1.8 | 116 | Curative (C) | 2020-07-22 | 2020-08-03 | Niraparib | 02 | N | NIRAPARIB | 100037693 |
| 160013780 | 160016717 | 1.61 | 61.8 | null | 2018-10-08 | 2018-10-22 | VAI (Ifos 3g/m2) | 02 | null | GEMCITABINE | 100980541 |
| 160014086 | 160016718 | 1.62 | 36.8 | Curative (C) | 2018-10-23 | 2018-11-17 | Niraparib | 02 | N | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 100998920 |
| 160014131 | 160016719 | 1.65 | 83 | null | 2018-03-31 | 2019-02-22 | STS Rhabdomyosarco RMS 2005 IVADoVV | 01 | null | GEMCITABINE | 101216764 |
| 160014432 | 160016721 | 1.6 | 5.8 | null | 2018-07-13 | 2018-07-22 | NB HRNBL-1 Isotretinoin | null | null | VAI | 101285374 |
| 160014575 | 160016722 | 1.67 | 72.5 | Adjuvant (A) | 2020-10-17 | 2020-10-18 | Cyclophosphamide + Vincristine | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + OBINUTUZUMAB + VINCRISTINE | 100932501 |
| 160014891 | 160016723 | 1.72 | 62.4 | null | 2017-11-16 | 2017-11-16 | Pemetrexed | 02 | null | STS RHABDO RMS 2005 VIN CYCLO | 101812067 |
| 160015510 | 160016724 | 1.59 | 19.2 | Palliative (P) | 2020-02-24 | 2020-02-26 | NB HRNBL-1 BUMEL MAT | 02 | N | IVA | 101243872 |
| 160015547 | 160016725 | null | 91.55 | null | 2018-08-01 | 2018-12-06 | null | 02 | null | STS RHABDOMYOSARCOMA RMS 2005 IVADO | 101260596 |
| 160015614 | 160016726 | 1.54 | 93.9 | Palliative (P) | 2014-08-07 | 2014-08-07 | Doxorubicin + Ifosfamide | 02 | N | STS RHABDO RMS 2005 VIN CYCLO | 100093550 |
| 160015644 | 160016727 | 1.62 | 12 | null | null | null | TRANSPLANT MELPHALAN + TREOSULFAN | 01 | null | ATOMIC-MESO TRIAL | 101691294 |
| 160015907 | 160016728 | 1.53 | 70 | Palliative (P) | 2018-01-30 | 2018-02-27 | Dacarbazine | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101523408 |
| 160016067 | 160016729 | 1.6 | 84.6 | Palliative (P) | 2019-10-08 | 2020-08-17 | Cyclophosphamide oral | 01 | N | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 100042257 |
| 160016294 | 160016730 | 1.85 | 92.9 | Palliative (P) | 2018-08-03 | 2018-11-15 | EW EuroEwing 2012 Arm A VAC | 02 | N | EW EUROEWING 2012 ARM A VAI | 100012257 |
| 160016351 | 160016731 | null | 88 | Curative (C) | 2014-03-10 | 2014-03-16 | GEMCITABINE | N | N | GEMCARBO | 100433377 |
| 160016392 | 160016732 | 1.8 | 34.4 | Palliative (P) | 2018-02-19 | 2018-05-19 | EW EuroEwing 2012 Arm B VC | 01 | N | CISPLATIN + GEMCITABINE | 101645454 |
| 160016734 | 160016734 | 1.72 | 67.8 | Palliative (P) | 2018-10-05 | 2018-10-05 | VINCRISTINE | 02 | N | CABOZANTINIB | 100068510 |
| 160017049 | 160016735 | 1.67 | 89.6 | Curative (C) | 2018-04-08 | 2018-04-23 | ETOPOSIDE | 02 | N | EURO-EWING | 101696667 |
| 160017106 | 160016737 | 1.56 | 16.1 | Curative (C) | 2018-12-06 | 2018-12-06 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | CISPLATIN + ETOPOSIDE | 100451101 |
| 160017330 | 160016738 | 1.46 | 100.4 | Curative (C) | 2018-08-28 | 2019-02-14 | CONFIRM TRIAL | 02 | N | TRIAL | 101791368 |
| 160017345 | 160016739 | 1.55 | 39.4 | null | 2016-06-07 | 2017-06-21 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | ETOPOSIDE | 101752473 |
| 160017371 | 160016740 | 1.61 | 88 | null | 2018-03-01 | 2018-03-01 | Olaratumab | 01 | null | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 101632066 |
| 160017512 | 160016741 | 1.76 | 114.6 | null | 2018-11-28 | 2018-12-26 | Etoposide oral | 01 | null | CONFIRM TRIAL | 101539516 |
| 160007409 | 160016743 | 1.8 | 49.95 | Curative (C) | 2019-07-29 | 2019-07-29 | CONFIRM TRIAL | N | Y | NB HRNBL-1 COJEC IND COURSE C | 101332352 |
| 160009398 | 160016745 | null | 50.9 | null | null | 2016-12-06 | EW EuroEwing 2012 Arm A VAC | 99 | null | NOT MATCHED | 101361877 |
| 160009742 | 160016746 | 1.59 | 63.7 | null | 2016-09-21 | 2018-02-26 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | NB HRNBL-1 BUMEL MAT | 101683016 |
| 160012676 | 160016747 | 1.56 | 82.2 | Palliative (P) | 2019-12-04 | 2019-12-04 | NB HRNBL-1 BUMEL MAT | N | N | EW EUROEWING 2012 ARM B VC | 101571023 |
| 160013461 | 160016748 | 0 | 58.2 | null | null | 2018-10-17 | NB HRNBL-1 COJEC Ind COURSE C | 01 | null | EURO-EWING | 101452805 |
| 160014160 | 160016750 | 1.6 | 102 | Curative (C) | 2020-04-04 | 2020-04-05 | Methotrexate High Dose (3g/m2) | 02 | N | NB RELAPSED CCLG GUIDELINES TVD | 101205055 |
| 160016567 | 160016751 | 0 | 9.6 | null | null | 2021-07-27 | Olaparib | null | null | TEMOZOLOMIDE | 101213411 |
| 160007009 | 160017140 | null | null | null | null | 2019-05-24 | null | null | null | CARBOPLATIN + PEMETREXED | 101792960 |
| 160007017 | 160017141 | null | 60.7 | Palliative (P) | null | 2019-05-21 | Carboplatin + Pemetrexed | null | N | CARBOPLATIN + PEMETREXED | 101021298 |
| 160007141 | 160017149 | null | 85 | Palliative (P) | null | 2018-11-18 | Carboplatin + Pemetrexed | null | N | CARBOPLATIN + PEMETREXED | 100720061 |
| 160007181 | 160017150 | null | null | null | null | 2019-03-18 | null | null | null | CARBOPLATIN + PEMETREXED | 101256541 |
| 160007197 | 160017152 | null | null | null | null | 2020-11-12 | null | null | null | CARBOPLATIN + PEMETREXED | 101197918 |
| 160007278 | 160017156 | null | null | null | null | 2019-02-26 | null | 02 | null | CARBOPLATIN + PEMETREXED | 101813805 |
| 160007318 | 160017158 | null | null | null | null | 2020-06-15 | null | null | null | CARBOPLATIN + PEMETREXED | 100454945 |
| 160007333 | 160017159 | 1.77 | 71 | Palliative (P) | null | 2017-12-21 | Carboplatin + Pemetrexed | N | N | CARBOPLATIN + PEMETREXED | 101591382 |